Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
cholesterol molecule silhouette

Jul 24, 2026

NewAmsterdam Pharma and Menarini Receive Positive CHMP Opinion for Obicetrapib and Obicetrapib/Ezetimibe in Europe

NewAmsterdam Pharma and Menarini have received a favorable opinion from the CHMP regarding their cholesterol-lowering treatments, obicetrapib and its combination with ezetimibe, paving the way for potential commercialization in Europe.This positive recommendation is founded on robust data from Phase 3 clinical trials—BROADWAY, BROOKLYN, and TANDEM—demonstrating significant reductions in low-density lipoprotein cholesterol (LDL-C). Specifically, obicetrapib monotherapy showed up to a 40% decrease
A flat illustration of a syringe and a pill representing health technology.

Jul 24, 2026

Senate Begins Consideration of Landmark Bill to Regulate AI Diagnostics, IVF, and Emerging Health Technologies

The Nigerian Senate has initiated discussions on a significant bill aimed at modernizing regulations surrounding emerging health technologies, including AI-assisted diagnostics and other biotech innovations.This proposed legislation seeks to replace outdated laws governing food and medical products with a comprehensive framework that aligns with current global standards. Senator Suleiman Sadiq emphasized the need for this update, noting that existing regulations do not adequately address advance
Minimalist illustration of an IVD instrument with cloud connectivity

Jul 24, 2026

LRE Medical to Showcase Connected, AI-Ready IVD Instrument Framework at ADLM 2026 | Newswise

LRE Medical is set to highlight its innovative connected IVD instrument framework at ADLM 2026, showcasing the integration of secure connectivity from the initial design phase. This demonstration will illustrate the synergy between embedded software, cloud connectivity, and cybersecurity, enabling remote services and future AI applications.The evolution of diagnostic instruments towards software-defined solutions emphasizes connectivity as a foundational element rather than an optional feature.
A minimalist representation of AI and technology in science.

Jul 24, 2026

White House offers its science blueprint: More AI, less life sciences

The White House has unveiled a new science strategy that emphasizes artificial intelligence over traditional life sciences research, raising concerns among advocates for academic research.The report, titled "Science: A New Golden Age," was presented by Michael Kratsios, the science adviser to the Trump administration. It aims to redirect significant funding—potentially hundreds of billions of dollars—from universities towards industry, particularly focusing on technology and AI sectors. This shi
A stethoscope on a patient's chest in a dimly lit clinical room

Jul 24, 2026

Cambridge's TidalSense raises €16.6 million to turn the tide on respiratory diagnostics with patented AI tech

TidalSense, a Cambridge-based company specializing in AI-driven respiratory diagnostics, has secured €16.6 million ($19 million) in funding to enhance its commercial efforts in the UK and expand globally, particularly into the USA. This latest investment round included contributions from Cross-Border Impact Ventures and returning investors like BGF and Airstream Capital, bringing the company’s total funding to €35.1 million ($40 million), which includes significant grants from various UK health
A minimalist illustration of a pill bottle representing pharmacy operations.

Jul 24, 2026

LataMed AI and FARMASER Enter Memorandum of Understanding to Develop Automation Platform for Pharmacy Operations

LataMed AI Corp. has announced a collaboration with FARMASER to develop an advanced automation platform aimed at enhancing pharmacy operations in Latin America.The memorandum of understanding between LataMed AI and FARMASER focuses on creating a tailored artificial intelligence and automation solution that will support existing pharmacy workflows and facilitate expansion plans. The partnership will involve defining the technical and operational requirements, adapting the software to specific nee
A minimalist illustration of a leaf symbolizing sustainable agriculture.

Jul 24, 2026

Korea, Europe partner on AI, green biotech for future farming

Korea is forging partnerships with European scientists to advance sustainable agriculture through AI and green biotechnology, addressing global challenges like climate change and energy transitions.At the recent 18th Europe-Korea Conference on Science and Technology in Toulouse, France, Korea's Rural Development Administration (RDA) showcased its innovative agricultural strategies. The conference, attended by around 1,000 experts, focused on the transformative impact of AI and biotechnology on f
A burnt apartment office after an arson incident, showing damaged furniture and walls.

Jul 24, 2026

1 dead after apartment office arson in southeastern city

A tragic incident in Gyeongsan has resulted in the death of a woman in her 50s due to injuries sustained from an arson attack at an apartment management office. The attack, which occurred earlier this week, led to a fire and explosion that injured eight individuals.The Gyeongbuk Provincial Police reported that the woman succumbed to her injuries at a local hospital following the Thursday incident. A 71-year-old man, identified only by his surname Yoo, has been arrested as the primary suspect. He
Lucica® Glycated Albumin-L assay kit in a clinical setting

Jul 24, 2026

Precision Diabetes and Nagase Diagnostics Announce Exclusive U.S. Commercialization Partnership for Lucica® Glycated Albumin-L, the Only FDA-Cleared Assay Specifically Measured Glycated Albumin in the United States

Precision Diabetes and Nagase Diagnostics have formed an exclusive partnership to commercialize the FDA-cleared Lucica® Glycated Albumin-L assay in the U.S., enhancing diabetes management capabilities.This collaboration aims to broaden access to a significant glycemic biomarker that serves as an intermediate-term measure of glycemic control, complementing established methods like HbA1c and Continuous Glucose Monitoring (CGM). The Lucica® Glycated Albumin-L assay offers insights into glycemic sta
A minimalist illustration of a molecule and a contract representing biotech growth.

Jul 24, 2026

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

MindWalk Holdings Corp. has reported significant financial growth, showcasing the tangible impact of its AI-driven drug discovery platform.In its recent fiscal report, MindWalk Holdings, a company specializing in AI applications for drug discovery, announced a 46% revenue increase, reaching C$15.6 million. This surge is coupled with a notable reduction in net losses, which fell by over 50% to C$13.9 million. The company also achieved a critical milestone by signing its first two recurring enterp
A fire-control system on a workbench in a dimly lit maintenance hub.

Jul 23, 2026

Finland is building Europe's first maintenance hub for MLRS rocket fire-control systems, and it's quietly tied to the F-35 program

Finland is establishing Europe's first maintenance hub for the Common Fire Control System, crucial for M270A2 and HIMARS rocket launchers, marking a significant step in enhancing its defense capabilities.The Finnish Defense Forces, in collaboration with Tampere-based Insta and Lockheed Martin, signed an agreement to set up this specialized facility in Tampere. This center will focus on the electronic fire-control systems essential for the operation of these launchers, rather than the rocket syst
A vial of medication on a lab bench with compliance documents in the background.

Jul 23, 2026

Tarini Mohapatra: The 1.2 Million Dollar Lesson That Changed Life Sciences Compliance Forever

In the evolving landscape of life sciences, the integration of AI into compliance frameworks is becoming critical for success.Tarini Mohapatra, CEO and Co-Founder of TFives, reflects on a significant learning experience where an AI solution for detecting adverse drug reactions, despite achieving 85% accuracy, faced an 18-month delay due to compliance issues. This situation underscored a fundamental challenge in regulated environments: successful models can become liabilities without proper evide